Suppr超能文献

高突变IgD多发性骨髓瘤中Iglambda表达偏倚并非源于受体修正。

Biased Iglambda expression in hypermutated IgD multiple myelomas does not result from receptor revision.

作者信息

van der Burg M, Bende R J, Aarts W M, Langerak A W, van Dongen J J M, van Noesel C J M

机构信息

Dept of Immunology, Erasmus University Rotterdam/University Hospital Rotterdam, The Netherlands.

出版信息

Leukemia. 2002 Jul;16(7):1358-61. doi: 10.1038/sj.leu.2402513.

Abstract

Normal IgM(-)IgD(+) CD38(+) B cells and IgM(-)IgD(+) multiple myelomas (MM) are characterized by Cmu deletion, biased Iglambda expression and hypermutated IgV regions. The predominant Iglambda usage has been proposed as resulting from secondary Ig gene rearrangements during extensive clonal expansion in the germinal center environment. Here, four cases of IgDlambda MM were studied to address the question of light chain receptor revision in a 'single cell' model. Detailed analyses of both IGK and IGL alleles of each case were performed by Southern blotting, (RT-) PCR, and sequencing. The expressed IgV genes were extensively mutated and Cmu deletion was confirmed in two cases. In addition, in the four MM a total of six non-functional deletional IGK rearrangements were identified, which proved to be unmutated. We conclude that IgD myelomas indeed originate from (post) germinal center B cells in which, in spite of the fact that they are hypermutated, there is no evidence of receptor revision.

摘要

正常IgM(-)IgD(+) CD38(+) B细胞和IgM(-)IgD(+)多发性骨髓瘤(MM)的特征是Cμ缺失、Iglambda表达偏向和IgV区超突变。有人提出,主要的Iglambda使用是由于生发中心环境中广泛克隆扩增期间的继发性Ig基因重排所致。在此,研究了4例IgDlambda MM病例,以在“单细胞”模型中解决轻链受体修正问题。通过Southern印迹、(RT-)PCR和测序对每个病例的IGK和IGL等位基因进行了详细分析。表达的IgV基因广泛突变,两例证实存在Cμ缺失。此外,在这4例MM中总共鉴定出6种无功能的缺失性IGK重排,这些重排未发生突变。我们得出结论,IgD骨髓瘤确实起源于(生发中心后)B细胞,尽管这些B细胞发生了超突变,但没有受体修正的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验